BEST DIGITAL NEWS START-UP, WAN-IFRA 2019 GOLD AWARD

BT EXCLUSIVE

Singapore still falling short for home-grown biotechs seeking IPO

BT EXCLUSIVE

Singapore still falling short for home-grown biotechs seeking IPO

Tough SGX mainboard listing rules, low liquidity, lack of deep institutional investor pool and sparse research ecosystem among reasons cited
6 -min read
Listen to this article
Tough SGX mainboard listing rules, low liquidity, lack of deep institutional investor pool and sparse research ecosystem among reasons cited
6 -min read
Listen to this article

Singapore

HOME-GROWN biotech companies would rather look for opportunities further ashore than list on the Singapore Exchange (SGX). Although the city-state has a growing biotech ecosystem, the local bourse has not been able to benefit much from it.

Industry players who spoke to...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes